The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
S100b as a Prognostic Biomarker in Outcome Prediction for Patients with Severe Traumatic Brain Injury
Open accessAbstract
As an astrocytic protein specific to the central nervous system, S100b is a potentially useful marker in outcome prediction after traumatic brain injury (TBI). Some studies have questioned the validity of S100b, citing the extracerebral origins of the protein as reducing the specificity of the marker. This study evaluated S100b as a prognostic biomarker in adult subjects with severe TBI (sTBI) by comparing outcomes with S100b temporal profiles generated from both cerebrospinal fluid (CSF) (n = 138 subjects) and serum (n = 80 subjects) samples across a 6-day time course. Long-bone fracture, Injury Severity Score (ISS), and isolated head injury status were variables used to assess extracerebral sources of S100b in serum. After TBI, CSF and serum S100b levels were increased over healthy controls across the first 6 days post-TBI (p ≤ 0.005 and p ≤ 0.031). Though CSF and serum levels were highly correlated during early time points post-TBI, this association diminished over time. Bivariate analysis showed that subjects who had temporal CSF profiles with higher S100b concentrations had higher acute mortality (p < 0.001) and worse Glasgow Outcome Scale (GOS; p = 0.002) and Disability Rating Scale (DRS) scores (p = 0.039) 6 months post-injury. Possibly as a result of extracerebral sources of S100b in serum, as represented by high ISS scores (p = 0.032), temporal serum profiles were associated with acute mortality (p = 0.015). High CSF S100b levels were observed in women (p = 0.022) and older subjects (p = 0.004). Multivariate logistic regression confirmed CSF S100b profiles in predicting GOS and DRS and showed mean and peak serum S100b as acute mortality predictors after sTBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Intracellular and extracellular roles of S100 proteins
Donato, R. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10296 · Cited by 974 · cited 2×
“Proteomic biomarkers are a part of mainstream clinical care used to quantitatively assess and define injury in almost every organ system, except the brain.5,6 With the absence of specific prognostic tools, there is increasing interest in identifying biomarkers that are both sensitive and specific to the central nervou…”
BackgroundPatient age and outcome following severe traumatic brain injury: an analysis of 5600 patients
Hukkelhoven, C. W. P. M., Steyerberg, E. W., Rampen, A. J. J., Farace, E., Habbema, J. D. F., Marshall, L. F., Murray, G. D., & Maas, A. I. R. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.4.0666 · Cited by 641
The Effect of Gender on Patients With Moderate to Severe Head Injuries
Berry, C., Ley, E. J., Tillou, A., Cryer, G., Margulies, D. R., & Salim, A. (2009) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e3181ba3354 · Cited by 197
Acute Serum Hormone Levels: Characterization and Prognosis after Severe Traumatic Brain Injury
Wagner, A. K., McCullough, E. H., Niyonkuru, C., Ozawa, H., Loucks, T. L., Dobos, J. A., Brett, C. A., Santarsieri, M., Dixon, C. E., Berga, S. L., et al. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1586 · Cited by 172 · cited 2×
“We have used this approach in previous studies assessing the ability of temporal biomarker patterns to predict TBI outcome.(44,45,46) S100b TRAJ groups were formulated with 80 patients having serum measurements and 138 subjects having CSF S100b measurements.”
BackgroundMethodSelf-citation
Cited by
Thelin, E. P., Nelson, D. W., & Bellander, B.-M. (2017) · Acta Neurochirurgica · doi:10.1007/s00701-016-3046-3 · Cited by 317
Thelin, E. P., Zeiler, F. A., Ercole, A., Mondello, S., Büki, A., Bellander, B.-M., Helmy, A., Menon, D. K., & Nelson, D. W. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00300 · Cited by 260
Vijapur, S. M., Yang, Z., Barton, D. J., Vaughan, L., Awan, N., Kumar, R. G., Oh, B.-M., Berga, S. L., Wang, K. K., & Wagner, A. K. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6780 · Cited by 20
Self-citation
Metadata
- Authors
- Goyal, A., Failla, M. D., Niyonkuru, C., Amin, K., Fabio, A., Berger, R. P., & Wagner, A. K.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2013-06
- Volume
- 30
- Issue
- 11
- Pages
- 946-957
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2082100107
- Cited by
- 194
- References
- 6
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: S100b as a Prognostic Biomarker in Outcome Prediction for Patients with Severe Traumatic Brain Injury. https://app.cochat.ai/papers/10.1089/neu.2012.2579
- The paper
- Goyal, A., Failla, M. D., Niyonkuru, C., Amin, K., Fabio, A., Berger, R. P., & Wagner, A. K. (2013). S100b as a Prognostic Biomarker in Outcome Prediction for Patients with Severe Traumatic Brain Injury. Journal of Neurotrauma. https://doi.org/10.1089/neu.2012.2579
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.